Search Results - "Sierts, Jeroen A."

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Chylomicronemia With Low Postheparin Lipoprotein Lipase Levels in the Setting of GPIHBP1 Defects by Franssen, Remco, Young, Stephen G, Peelman, Frank, Hertecant, Jozef, Sierts, Jeroen A, Schimmel, Alinda W.M, Bensadoun, André, Kastelein, John J.P, Fong, Loren G, Dallinga-Thie, Geesje M, Beigneux, Anne P

    Published in Circulation. Cardiovascular genetics (01-04-2010)
    “…BACKGROUND—Recent studies in mice have established that an endothelial cell protein, glycosylphosphatidylinositol-anchored high-density lipoprotein-binding…”
    Get full text
    Journal Article
  7. 7

    Efficient lowering of triglyceride levels in mice by human apoAV protein variants associated with hypertriglyceridemia by Vaessen, Stefan F.C., Sierts, Jeroen A., Kuivenhoven, Jan Albert, Schaap, Frank G.

    “…Variation in the apolipoprotein A5 (APOA5) gene has consistently been associated with increased plasma triglyceride (TG) levels in epidemiological studies. In…”
    Get full text
    Journal Article
  8. 8

    Adeno-associated virus LPL(S447X) gene therapy in LDL receptor knockout mice by Rip, Jaap, Sierts, Jeroen A, Vaessen, Stefan F C, Kastelein, John J P, Twisk, Jaap, Kuivenhoven, Jan Albert

    Published in Atherosclerosis (01-09-2007)
    “…Overexpression of lipoprotein lipase (LPL) protects against atherosclerosis in genetically engineered mice. We tested whether a gene therapy vector that…”
    Get full text
    Journal Article
  9. 9

    AAV1-LPL(S447X) gene therapy reduces hypertriglyceridemia in apoE2 knock in mice by Rip, Jaap, van Dijk, Ko Willems, Sierts, Jeroen A, Kastelein, John J P, Twisk, Jaap, Kuivenhoven, Jan Albert

    Published in Biochimica et biophysica acta (01-10-2006)
    “…Intramuscular (IM) application of adeno-associated virus serotype 1 (AAV1) for the delivery of human lipoprotein lipase (hLPL) was previously shown efficacious…”
    Get more information
    Journal Article
  10. 10

    Adeno-associated virus LPLS447X gene therapy in LDL receptor knockout mice by Rip, Jaap, Sierts, Jeroen A, Vaessen, Stefan F.C, Kastelein, John J.P, Twisk, Jaap, Kuivenhoven, Jan Albert

    Published in Atherosclerosis (01-09-2007)
    “…Abstract Background Overexpression of lipoprotein lipase (LPL) protects against atherosclerosis in genetically engineered mice. We tested whether a gene…”
    Get full text
    Journal Article
  11. 11

    Adeno-associated virus LPL S447X gene therapy in LDL receptor knockout mice by Rip, Jaap, Sierts, Jeroen A., Vaessen, Stefan F.C., Kastelein, John J.P., Twisk, Jaap, Kuivenhoven, Jan Albert

    Published in Atherosclerosis (2007)
    “…Overexpression of lipoprotein lipase (LPL) protects against atherosclerosis in genetically engineered mice. We tested whether a gene therapy vector that…”
    Get full text
    Journal Article
  12. 12
  13. 13

    AAV1-LPL S447X gene therapy reduces hypertriglyceridemia in apoE2 knock in mice by Rip, Jaap, van Dijk, Ko Willems, Sierts, Jeroen A., Kastelein, John J.P., Twisk, Jaap, Kuivenhoven, Jan Albert

    “…Intramuscular (IM) application of adeno-associated virus serotype 1 (AAV1) for the delivery of human lipoprotein lipase (hLPL) was previously shown efficacious…”
    Get full text
    Journal Article
  14. 14

    907. Gene Therapy for Genetic Lipoprotein Lipase (LPL) Deficiency; an Update by Rip, Jaap, Nierman, Melchior C, Sierts, Jeroen A, Ross, Colin J, Hayden, Michael R, De Jong, Albertine, Dijkhuizen, Paul, Hermens, Wim, Twisk, Jaap, Kastelein, John J, Kuivenhoven, Jan Albert, Meulenberg, Janneke M

    Published in Molecular therapy (01-05-2005)
    “…Lipoprotein lipase (LPL) deficiency cannot be effectively treated and causes severe hypertriglyceridemia and pancreatitis. We have reported that…”
    Get full text
    Journal Article